• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Achieving Justice in Genomic Translation

Achieving Justice in Genomic Translation

Re-Thinking the Pathway to Benefit

9780195390384
358,02 zł
322,22 zł Zniżka 35,80 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 322,22 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This book explores implicit choices made by researchers, policy makers, and funders regarding who benefits from societys investment in health research. The authors focus specifically on genetic research and examine whether such research tends to reduce or exacerbate existing health disparities. Using case examples to illustrate the issues, the authors trace the path of genetics research from discovery, through development and delivery, to health outcomes. Topics include breastcancer screening and treatment, autism research, pharmacogenetics, prenatal testing, newborn screening, and youth suicide prevention. Each chapter emphasizes the societal context of genetic research and illustrates how science might change if attention were paid to the needs of marginalized populations.Written by experts in genetics, health, and philosophy, this book argues that the scientific enterprise has a responsibility to respond to community needs to assure that research innovations achieve much needed health impacts.
Szczegóły produktu
OUP USA
86530
9780195390384
9780195390384

Opis

Rok wydania
2011
Numer wydania
1
Oprawa
twarda
Liczba stron
224
Wymiary (mm)
156 x 235
Waga (g)
494
  • 1. Making Good on the Promise of Genetics: Justice in Translational Science; Sara Goering, Suzanne Holland, and Kelly A. Edwards; 2. The Social, Political, and Economic Underpinnings of Biomedical Research and Development: A Formidable Status Quo; Patricia Kuszler; 3. The Input-Output Problem: Whose DNA Do We Study, and Why Does It Matter?; Stephanie Malia Fullerton; 4. The Autism Genetic Resource Exchange: Changing Pace, Priorities, and Roles in Discovery Science; Holly K. Tabor and Martine Lappe; Commentary on the Discovery Phase of Research; Sara Goering, Suzanne Holland, and Kelly A. Edwards; 5. Early Assessment of Translational Opportunities; Patricia Deverka and David L. Veenstra; 6. The power of knowledge: How carrier and prenatal screening altered the clinical goals of genetic testing; Commentary on the Development Phase of the Translational Cycle; 7. Integrating genetic tests into clinical practice: The role of guidelines; Anne-Marie Laberge and Wylie Burke; 8. Genomics and the Health Commons; Nora Henrikson and Wylie Burke; Commentary on the Delivery Phase of the Translational Cycle; Sara Goering, Suzanne Holland, and Kelly A. Edwards; 9. The Role of Advocacy in Newborn Screening; Catharine Riley and Carolyn Watts; 10. What Outcomes? Whose Benefits?; Wylie Burke and Nancy Press; Commentary on the Outcomes Phase of the Translational Cycle; Sara Goering, Suzanne Holland, and Kelly A. Edwards; 11. Bringing the Best Science to Bear on Youth Suicide: Why Community Perspectives Matter; Rosalina James and Helene Starks; 12. Conclusion; Kelly A. Edwards, Sara Goering, Suzanne Holland and Maureen Kelley;
Komentarze (0)